First Human Gets Cell-Reversing Gene Therapy for Blindness

A Boston biotech company has treated the first person with a gene therapy designed to reverse cellular aging in the human body.

The groundbreaking treatment targets serious eye diseases that cause blindness by resetting damaged cells to a younger, healthier state.